United Health Products to Present at the Life Sciences Virtual Investor Forum September 18th

Company Overview - United Health Products (UHP) is focused on the development and commercialization of innovative wound care technologies [1][3] - UHP has developed and patented a Neutralized Regenerated Cellulose hemostatic agent, specifically the CelluSTAT Hemostatic Gauze, designed to control mild to moderate bleeding [3] Upcoming Event - Brian Thom, CEO of UHP, will present live at the Life Sciences Virtual Investor Forum on September 18, 2025, at 10:30 am ET [1] - The event will allow investors to ask questions in real-time, and an archived webcast will be available for those unable to attend live [1] Investor Engagement - The Virtual Investor Conferences (VIC) platform provides an interactive forum for publicly traded companies to present directly to investors [4] - VIC enhances investor access by replicating components of an on-site investor conference, allowing for targeted one-on-one meetings and dynamic video content [5]